NAPRC Accreditation Linked to Increased Rectal Cancer Patient Volume

Colorectal cancer remains one of the most prevalent malignancies in the United States, with the number of survivors projected to exceed 22 million by 2035 [1]. Despite advancements in early detection and treatment, significant disparities persist in the delivery of high-quality surgical care, particularly for vulnerable populations [2]. Managing rectal adenocarcinoma requires a complex, multidisciplinary approach to navigate the risks of postoperative complications, such as infections and wound healing disorders, which are further exacerbated by comorbidities like diabetes [3]. While adherence to guideline-concordant care is known to improve survival outcomes, the institutional burden of maintaining these rigorous standards often requires extensive staffing and infrastructure [2]. To understand whether this heavy institutional investment yields tangible shifts in care delivery, researchers recently evaluated how formal accreditation programs influence patient volumes and procedural patterns in this high-stakes clinical environment.